HYUNDAI PHARM

The current price of 004310 is 3750 KRW — it has decreased by 1.06% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HYUNDAI PHARM stocks are traded under the ticker 004310.

004310 stock is 2.15% volatile and has beta coefficient of 0.39. Check out the list of the most volatile stocks — is HYUNDAI PHARM there?

Yes, you can track HYUNDAI PHARM financials in yearly and quarterly reports right on TradingView.

004310 stock has fallen by 1.83% compared to the previous week, the month change is a 3.23% fall, over the last year HYUNDAI PHARM has showed a 29.38% decrease.

004310 net income for the last quarter is ‪309.18 M‬ KRW, while the quarter before that showed ‪−430.92 M‬ KRW of net income which accounts for 171.75% change. Track more HYUNDAI PHARM financial stats to get the full picture.

Yes, 004310 dividends are paid annually. The last dividend per share was 35.00 KRW. As of today, Dividend Yield (TTM)% is 0.92%. Tracking HYUNDAI PHARM dividends might help you take more informed decisions.

Like other stocks, 004310 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYUNDAI PHARM stock right from TradingView charts — choose your broker and connect to your account.

004310 reached its all-time high on Dec 23, 2020 with the price of 11000 KRW, and its all-time low was 950 KRW and was reached on Jan 12, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 385.00 employees. See our rating of the largest employees — is HYUNDAI PHARM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HYUNDAI PHARM technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HYUNDAI PHARM stock shows the sell signal. See more of HYUNDAI PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HYUNDAI PHARM EBITDA is ‪8.88 B‬ KRW, and current EBITDA margin is 5.66%. See more stats in HYUNDAI PHARM financial statements.